Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Obesity: HELP
Articles from California
Based on 5,078 articles published since 2010
||||

These are the 5078 published articles about Obesity that originated from California during 2010-2020.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. 2019

Elmets, Craig A / Leonardi, Craig L / Davis, Dawn M R / Gelfand, Joel M / Lichten, Jason / Mehta, Nehal N / Armstrong, April W / Connor, Cody / Cordoro, Kelly M / Elewski, Boni E / Gordon, Kenneth B / Gottlieb, Alice B / Kaplan, Daniel H / Kavanaugh, Arthur / Kivelevitch, Dario / Kiselica, Matthew / Korman, Neil J / Kroshinsky, Daniela / Lebwohl, Mark / Lim, Henry W / Paller, Amy S / Parra, Sylvia L / Pathy, Arun L / Prater, Elizabeth Farley / Rupani, Reena / Siegel, Michael / Stoff, Benjamin / Strober, Bruce E / Wong, Emily B / Wu, Jashin J / Hariharan, Vidhya / Menter, Alan. ·University of Alabama, Birmingham, Alabama. · Central Dermatology, St. Louis, Missouri. · Mayo Clinic, Rochester, Minnesota. · University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. · National Psoriasis Foundation, Portland, Oregon. · National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland. · University of Southern California, Los Angeles, California. · Department of Dermatology, University of California San Francisco School of MedicineSan Francisco, California. · Medical College of Wisconsin, Milwaukee, Wisconsin. · Department of Dermatology, Icahn School of Medicine at Mt. Sinai, New York, New York. · University of Pittsburgh, Pennsylvania. · University of California San Diego, San Diego, California. · Baylor Scott and White, Dallas, Texas. · University Hospitals Cleveland Medical Center, Cleveland, Ohio. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Dermatology, Henry Ford Hospital, Detroit, Michigan. · Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Dermatology and Skin Surgery, Sumter, South Carolina. · Colorado Permanente Medical Group, Centennial, Colorado. · University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Icahn School of Medicine at Mount Sinai, New York, New York. · Emory University School of Medicine, Atlanta, Georgia. · University of Connecticut, Farmington, Connecticut; Probity Medical Research, Waterloo, Canada. · San Antonio Uniformed Services Health Education Consortium, Joint-Base San Antonio, Texas. · Dermatology Research and Education Foundation, Irvine, California. · American Academy of Dermatology, Rosemont, Illinois. Electronic address: vhariharan@aad.org. ·J Am Acad Dermatol · Pubmed #30772097.

ABSTRACT: Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations on the basis of available evidence.

2 Guideline Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement. 2018

Anonymous1151152 / Curry, Susan J / Krist, Alex H / Owens, Douglas K / Barry, Michael J / Caughey, Aaron B / Davidson, Karina W / Doubeni, Chyke A / Epling, John W / Grossman, David C / Kemper, Alex R / Kubik, Martha / Landefeld, C Seth / Mangione, Carol M / Phipps, Maureen G / Silverstein, Michael / Simon, Melissa A / Tseng, Chien-Wen / Wong, John B. ·University of Iowa, Iowa City. · Fairfax Family Practice Residency, Fairfax, Virginia. · Virginia Commonwealth University, Richmond. · Veterans Affairs Palo Alto Health Care System, Palo Alto, California. · Stanford University, Stanford, California. · Harvard Medical School, Boston, Massachusetts. · Oregon Health & Science University, Portland. · Columbia University, New York, New York. · University of Pennsylvania, Philadelphia. · Virginia Tech Carilion School of Medicine, Roanoke. · Kaiser Permanente Washington Health Research Institute, Seattle. · Nationwide Children's Hospital, Columbus, Ohio. · Temple University, Philadelphia, Pennsylvania. · University of Alabama at Birmingham. · University of California, Los Angeles. · Brown University, Providence, Rhode Island. · Boston University, Boston, Massachusetts. · Northwestern University, Evanston, Illinois. · University of Hawaii, Honolulu. · Pacific Health Research and Education Institute, Honolulu, Hawaii. · Tufts University, Medford, Massachusetts. ·JAMA · Pubmed #30326502.

ABSTRACT: Importance: More than 35% of men and 40% of women in the United States are obese. Obesity is associated with health problems such as increased risk for coronary heart disease, type 2 diabetes, various types of cancer, gallstones, and disability. Obesity is also associated with an increased risk for death, particularly among adults younger than 65 years. Objective: To update the US Preventive Services Task Force (USPSTF) 2012 recommendation on screening for obesity in adults. Evidence Review: The USPSTF reviewed the evidence on interventions (behavioral and pharmacotherapy) for weight loss or weight loss maintenance that can be provided in or referred from a primary care setting. Surgical weight loss interventions and nonsurgical weight loss devices (eg, gastric balloons) are considered to be outside the scope of the primary care setting. Findings: The USPSTF found adequate evidence that intensive, multicomponent behavioral interventions in adults with obesity can lead to clinically significant improvements in weight status and reduce the incidence of type 2 diabetes among adults with obesity and elevated plasma glucose levels; these interventions are of moderate benefit. The USPSTF found adequate evidence that behavior-based weight loss maintenance interventions are of moderate benefit. The USPSTF found adequate evidence that the harms of intensive, multicomponent behavioral interventions (including weight loss maintenance interventions) in adults with obesity are small to none. Therefore, the USPSTF concludes with moderate certainty that offering or referring adults with obesity to intensive behavioral interventions or behavior-based weight loss maintenance interventions has a moderate net benefit. Conclusions and Recommendation: The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral interventions. (B recommendation).

3 Guideline American Society for Metabolic and Bariatric Surgery and American Hernia Society consensus guideline on bariatric surgery and hernia surgery. 2018

Menzo, Emanuele Lo / Hinojosa, Marcelo / Carbonell, Alfredo / Krpata, David / Carter, Jonathan / Rogers, Ann M. ·Section of Minimally Invasive and Endoscopic Surgery, Cleveland Clinic Florida, The Bariatric and Metabolic Institute, Weston, Florida. · Department of Surgery, University of California, Irvine Medical Center, Irvine, California. · Department of Surgery, Division of Minimal Access and Bariatric Surgery, Greenville Health System, University of South Carolina School of Medicine, Greenville, South Carolina. · Comprehensive Hernia Center, Digestive Disease and Surgical Institute, The Cleveland Clinic Foundation, Cleveland, Ohio. · Department of Surgery, University of California-San Francisco, San Francisco, California. · Department of Surgery, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania. Electronic address: arogers@pennstatehealth.psu.edu. ·Surg Obes Relat Dis · Pubmed #30154033.

ABSTRACT: The American Society for Metabolic and Bariatric Surgery issues the following guidelines for the purpose of enhancing quality of care in hernia treatment through metabolic and bariatric surgery. In this statement, suggestions for management are presented that are derived from available knowledge, peer-reviewed scientific literature, and expert opinion. This was accomplished by performing a review of currently available literature regarding obesity, obesity treatments, and hernia surgery. The intent of issuing such a guideline is to provide objective information regarding the impact of obesity treatment on effective and durable hernia repair. The guideline may be revised in the future should additional evidence become available.

4 Guideline Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. 2017

Styne, Dennis M / Arslanian, Silva A / Connor, Ellen L / Farooqi, Ismaa Sadaf / Murad, M Hassan / Silverstein, Janet H / Yanovski, Jack A. ·University of California Davis, Sacramento, California 95817. · University of Pittsburgh, Pittsburgh, Pennsylvania 15224. · University of Wisconsin, Madison, Wisconsin 53792. · University of Cambridge, Cambridge CB2 0QQ, United Kingdom. · Mayo Clinic, Rochester, Minnesota 55905. · University of Florida, Gainesville, Florida 32607; and. · National Institutes of Health, Bethesda, Maryland 20892. ·J Clin Endocrinol Metab · Pubmed #28359099.

ABSTRACT: Cosponsoring Associations: The European Society of Endocrinology and the Pediatric Endocrine Society. This guideline was funded by the Endocrine Society. Objective: To formulate clinical practice guidelines for the assessment, treatment, and prevention of pediatric obesity. Participants: The participants include an Endocrine Society-appointed Task Force of 6 experts, a methodologist, and a medical writer. Evidence: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation approach to describe the strength of recommendations and the quality of evidence. The Task Force commissioned 2 systematic reviews and used the best available evidence from other published systematic reviews and individual studies. Consensus Process: One group meeting, several conference calls, and e-mail communications enabled consensus. Endocrine Society committees and members and co-sponsoring organizations reviewed and commented on preliminary drafts of this guideline. Conclusion: Pediatric obesity remains an ongoing serious international health concern affecting ∼17% of US children and adolescents, threatening their adult health and longevity. Pediatric obesity has its basis in genetic susceptibilities influenced by a permissive environment starting in utero and extending through childhood and adolescence. Endocrine etiologies for obesity are rare and usually are accompanied by attenuated growth patterns. Pediatric comorbidities are common and long-term health complications often result; screening for comorbidities of obesity should be applied in a hierarchal, logical manner for early identification before more serious complications result. Genetic screening for rare syndromes is indicated only in the presence of specific historical or physical features. The psychological toll of pediatric obesity on the individual and family necessitates screening for mental health issues and counseling as indicated. The prevention of pediatric obesity by promoting healthful diet, activity, and environment should be a primary goal, as achieving effective, long-lasting results with lifestyle modification once obesity occurs is difficult. Although some behavioral and pharmacotherapy studies report modest success, additional research into accessible and effective methods for preventing and treating pediatric obesity is needed. The use of weight loss medications during childhood and adolescence should be restricted to clinical trials. Increasing evidence demonstrates the effectiveness of bariatric surgery in the most seriously affected mature teenagers who have failed lifestyle modification, but the use of surgery requires experienced teams with resources for long-term follow-up. Adolescents undergoing lifestyle therapy, medication regimens, or bariatric surgery for obesity will need cohesive planning to help them effectively transition to adult care, with continued necessary monitoring, support, and intervention. Transition programs for obesity are an uncharted area requiring further research for efficacy. Despite a significant increase in research on pediatric obesity since the initial publication of these guidelines 8 years ago, further study is needed of the genetic and biological factors that increase the risk of weight gain and influence the response to therapeutic interventions. Also needed are more studies to better understand the genetic and biological factors that cause an obese individual to manifest one comorbidity vs another or to be free of comorbidities. Furthermore, continued investigation into the most effective methods of preventing and treating obesity and into methods for changing environmental and economic factors that will lead to worldwide cultural changes in diet and activity should be priorities. Particular attention to determining ways to effect systemic changes in food environments and total daily mobility, as well as methods for sustaining healthy body mass index changes, is of importance.

5 Guideline White Paper AGA: POWER - Practice Guide on Obesity and Weight Management, Education, and Resources. 2017

Acosta, Andres / Streett, Sarah / Kroh, Mathew D / Cheskin, Lawrence J / Saunders, Katherine H / Kurian, Marina / Schofield, Marsha / Barlow, Sarah E / Aronne, Louis. ·Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: acostacardenas.andres@mayo.edu. · Inflammatory Bowel Disease, Stanford University School of Medicine, Stanford, California. · Department of Surgical Endoscopy, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio. · Johns Hopkins Weight Management Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. · Comprehensive Weight Control Center, Weill Cornell Medical College, New York, New York and representative of The Obesity Society. · Department of Minimally Invasive Surgery, New York University, New York, New York. · Nutrition Services Coverage, Academy of Nutrition and Dietetics, Chicago, Illinois. · Baylor College of Medicine and Center for Childhood Obesity, Texas Children's Hospital, Houston, Texas and representative of North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. ·Clin Gastroenterol Hepatol · Pubmed #28242319.

ABSTRACT: The epidemic of obesity continues at alarming rates, with a high burden to our economy and society. The American Gastroenterological Association understands the importance of embracing obesity as a chronic, relapsing disease and supports a multidisciplinary approach to the management of obesity. Because gastrointestinal disorders resulting from obesity are more frequent and often present sooner than type 2 diabetes mellitus and cardiovascular disease, gastroenterologists have an opportunity to address obesity and provide an effective therapy early. Patients who are overweight or obese already fill gastroenterology clinics with gastroesophageal reflux disease and its associated risks of Barrett's esophagus and esophageal cancer, gallstone disease, nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, and colon cancer. Obesity is a major modifiable cause of diseases of the digestive tract that frequently goes unaddressed. As internists, specialists in digestive disorders, and endoscopists, gastroenterologists are in a unique position to play an important role in the multidisciplinary treatment of obesity. This American Gastroenterological Association paper was developed with content contribution from Society of American Gastrointestinal and Endoscopic Surgeons, The Obesity Society, Academy of Nutrition and Dietetics, and North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, endorsed with input by American Society for Gastrointestinal Endoscopy, American Society for Metabolic and Bariatric Surgery, American Association for the Study of Liver Diseases, and Obesity Medicine Association, and describes POWER: Practice Guide on Obesity and Weight Management, Education and Resources. Its objective is to provide physicians with a comprehensive, multidisciplinary process to guide and personalize innovative obesity care for safe and effective weight management.

6 Guideline American Society for Metabolic and Bariatric Surgery position statement on intragastric balloon therapy endorsed by the Society of American Gastrointestinal and Endoscopic Surgeons. 2016

Ali, Mohamed R / Moustarah, Fady / Kim, Julie J / Anonymous550864. ·Department of Surgery, University of California-Davis Medical Center, Sacramento, California. Electronic address: mrali@ucdavis.edu. · Faculty of Medical Sciences & Neuroscience Research Center, Lebanese University, Beirut, Lebanon; Department of Surgery, Central Michigan University College of Medicine, Mount Pleasant, Michigan. · Department of Surgery, Tufts University School of Medicine, Boston, Massachusetts. ·Surg Obes Relat Dis · Pubmed #27056407.

ABSTRACT: -- No abstract --

7 Guideline Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA). 2016

Bays, Harold / Kothari, Shanu N / Azagury, Dan E / Morton, John M / Nguyen, Ninh T / Jones, Peter H / Jacobson, Terry A / Cohen, David E / Orringer, Carl / Westman, Eric C / Horn, Deborah B / Scinta, Wendy / Primack, Craig. ·Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky. · Department of General Surgery, Gundersen Health System, La Crosse, Wisconsin. Electronic address: snkothar@gundersenhealth.org. · Department of Surgery, Stanford University School of Medicine, Palo Alto, California. · Department of Surgery, University of California Irvine Medical Center, Orange, California. · Methodist DeBakey Heart and Vascular Center, Baylor College of Medicine, Houston, Texas. · Department of Medicine, Emory University, Atlanta, Georgia. · Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · University of Miami Hospital, Miami, Florida. · Duke University Health System, Durham, North Carolina. · University of Texas Medical School, Houston, Texas. · Medical Weight Loss of New York, Fayetteville, New York. · Scottsdale Weight Loss, Scottsdale, Arizona. ·Surg Obes Relat Dis · Pubmed #27050404.

ABSTRACT: Bariatric procedures generally improve dyslipidemia, sometimes substantially so. Bariatric procedures also improve other major cardiovascular risk factors. This 2-part Scientific Statement examines the lipid effects of bariatric procedures and reflects contributions from authors representing the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and the Obesity Medicine Association (OMA). Part 1 was published in the Journal of Clinical Lipidology, and reviewed the impact of bariatric procedures upon adipose tissue endocrine and immune factors, adipose tissue lipid metabolism, as well as the lipid effects of bariatric procedures relative to bile acids and intestinal microbiota. This Part 2 reviews: (1) the importance of nutrients (fats, carbohydrates, and proteins) and their absorption on lipid levels; (2) the effects of bariatric procedures on gut hormones and lipid levels; (3) the effects of bariatric procedures on nonlipid cardiovascular disease (CVD) risk factors; (4) the effects of bariatric procedures on lipid levels; (5) effects of bariatric procedures on CVD; and finally, (6) the potential lipid effects of vitamin, mineral, and trace element deficiencies, that may occur after bariatric procedures.

8 Guideline American Society for Metabolic and Bariatric Surgery position statement on long-term survival benefit after metabolic and bariatric surgery. 2016

Kim, Julie / Eisenberg, Dan / Azagury, Dan / Rogers, Ann / Campos, Guilherme M. ·Department of Surgery, Tufts University School of Medicine, Boston, Massachusetts. Electronic address: jkim7@tuftsmedicalcenter.org. · Department of Surgery, Veterans Affairs Palo Alto Health Care System, Palo Alto, California. · Department of Surgery, Stanford University School of Medicine, Palo Alto, California. · Department of Surgery, Penn State University, Hershey, Pennsylvania. · Division of Bariatric and Gastrointestinal Surgery, Department of Surgery, Virginia Commonwealth University, Richmond, Virginia. ·Surg Obes Relat Dis · Pubmed #26944548.

ABSTRACT: The following position statement has been issued by the American Society for Metabolic and Bariatric Surgery in response to numerous inquiries made to the Society by patients, physicians, society members, hospitals, health insurance payors, the media, and others regarding the benefit of metabolic and bariatric surgery on long-term survival. An overview of the current available published peer-reviewed scientific evidence is presented.

9 Editorial Impact of Nutrition and Diet on COVID-19 Infection and Implications for Kidney Health and Kidney Disease Management. 2020

Kalantar-Zadeh, Kamyar / Moore, Linda W. ·University of California Irvine, Orange, California. Electronic address: kkz@uci.edu. · Houston Methodist Hospital, Houston, Texas. ·J Ren Nutr · Pubmed #32291198.

ABSTRACT: -- No abstract --

10 Editorial Facing the Vexing Problem of Recurrent FSGS after Kidney Transplantation. 2020

Lafayette, Richard A. ·Division of Nephrology, Department of Medicine, Stanford University, Stanford, California czar@stanford.edu. ·Clin J Am Soc Nephrol · Pubmed #31995516.

ABSTRACT: -- No abstract --

11 Editorial Comment on: body contouring in adolescents after bariatric surgery. 2020

Pratt, Janey S A. ·Stanford University, Stanford, California. ·Surg Obes Relat Dis · Pubmed #31732477.

ABSTRACT: -- No abstract --

12 Editorial Editorial: Exposure to Endocrine-Disrupting Chemicals and Cardiometabolic Disease: A Developmental Origins Approach. 2019

Perng, Wei / Goodrich, Jaclyn M / Cardenas, Andres / Watkins, Deborah J. ·Lifcourse Epidemiology of Adiposity and Diabetes (LEAD) Center, University of Colorado Anschutz Medical Campus, Aurora, CO, United States. · Department of Epidemiology, Colorado School of Public Health, Aurora, CO, United States. · Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, MI, United States. · Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, MI, United States. · Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, CA, United States. ·Front Public Health · Pubmed #31649913.

ABSTRACT: -- No abstract --

13 Editorial The 2016 American Academy of Ophthalmology Recommendations for Hydroxychloroquine Dosing Give Accurate Advice for All Patients. 2019

Marmor, Michael F. ·Byers Eye Institute and Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California. Electronic address: marmor@stanford.edu. ·Ophthalmol Retina · Pubmed #31585708.

ABSTRACT: -- No abstract --

14 Editorial Liver transplantation for non-alcoholic steatohepatitis in Europe: Where do we stand? 2019

Durand, François / Pavesi, Marco / Cheung, Ramsey. ·Hepatology & Liver Intensive Care, Hospital Beaujon, Clichy, France; University Paris Diderot, Paris France. Electronic address: francois.durand@bjn.aphp.fr. · Data Management Centre, EF-CLIF, Barcelona, Spain. · Division of Gastroenterology and Hepatology, VA Palo Alto HCS and Stanford University, Palo Alto, CA, USA. ·J Hepatol · Pubmed #31229271.

ABSTRACT: -- No abstract --

15 Editorial Obesity, visceral adiposity, and prostate cancer: What is the role of lifestyle interventions? 2019

Shirazipour, Celina H / Freedland, Stephen J. ·Division of Hematology/Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California. · Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California. · Urology Section, Durham VA Medical Center, Durham, North Carolina. ·Cancer · Pubmed #31179532.

ABSTRACT: -- No abstract --

16 Editorial Does elevated bilirubin aid weight control by preventing development of hypothalamic leptin resistance? 2019

DiNicolantonio, James J / McCarty, Mark / OKeefe, James. ·Preventive Cardiology, Mid America Heart Institute, Kansas City, Missouri, USA. · Catalytic Longevity, Encinitas, California, USA. ·Open Heart · Pubmed #30997121.

ABSTRACT: -- No abstract --

17 Editorial Greening of the Heart and Mind. 2019

Balmes, John R. ·1 Department of Medicine University of California San Francisco CA. · 2 Division of Environmental Health Sciences School of Public Health University of California Berkeley CA. ·J Am Heart Assoc · Pubmed #30835595.

ABSTRACT: See Article by Wang et al.

18 Editorial Blood Pressure Monitoring in Obese Patients: What Is the Size of the Problem? 2019

Joosten, Alexandre / Rinehart, Joseph / Cannesson, Maxime. ·From the Department of Anesthesiology and Intensive Care, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud, Université Paris-Saclay, Hôpital De Bicêtre, Assistance Publique Hôpitaux de Paris, 78 Rue du Général Leclerc, 94270 Le Kremlin-Bicêtre, France. · Department of Anesthesiology & Perioperative Care, University of California Irvine, Orange, California. · Department of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine, Los Angeles, California. ·Anesth Analg · Pubmed #30789406.

ABSTRACT: -- No abstract --

19 Editorial The complicated effects of  obesity on cancer and immunotherapy. 2019

Wang, Ziming / Monjazeb, Arta M / Murphy, William J. ·Department of Dermatology, UC Davis School of Medicine, Sacramento, CA 95816, USA. · Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, UC School of Medicine, Sacramento, CA 95817, USA. · Department of Internal Medicine, Division of Hematology & Oncology, UC Davis School of Medicine, Sacramento, CA 95817, USA. ·Immunotherapy · Pubmed #30702013.

ABSTRACT: -- No abstract --

20 Editorial Prior Bariatric Surgery in Liver Transplant Candidates: Unforeseen Consequences? 2019

Sharpton, Suzanne R / Terrault, Norah A. ·Department of Medicine, Division of Gastroenterology, University of California San Francisco, San Francisco, CA. ·Liver Transpl · Pubmed #30585696.

ABSTRACT: -- No abstract --

21 Editorial The evolution of body composition in oncology-epidemiology, clinical trials, and the future of patient care: facts and numbers. 2018

Brown, Justin C / Cespedes Feliciano, Elizabeth M / Caan, Bette J. ·Pennington Biomedical Research Center, Baton Rouge, LA, USA. · Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA. · Kaiser Permanente Northern California, Oakland, CA, USA. ·J Cachexia Sarcopenia Muscle · Pubmed #30637983.

ABSTRACT: There is growing interest from the oncology community to understand how body composition measures can be used to improve the delivery of clinical care for the 18.1 million individuals diagnosed with cancer annually. Methods that distinguish muscle from subcutaneous and visceral adipose tissue, such as computed tomography (CT), may offer new insights of important risk factors and improved prognostication of outcomes over alternative measures such as body mass index. In a meta-analysis of 38 studies, low muscle area assessed from clinically acquired CT was observed in 27.7% of patients with cancer and associated with poorer overall survival [hazard ratio: 1.44, 95% CI: 1.32-1.56]. Therapeutic interventions such as lifestyle and pharmacotherapy that modify all aspects of body composition and reduce the incidence of poor clinical outcomes are needed in patients with cancer. In a meta-analysis of six randomized trials, resistance training exercise increased lean body mass assessed from dual-energy X-ray absorptiometry [mean difference (MD): +1.07 kg, 95% CI: 0.76-1.37; P < 0.001] and walking distance [MD: +143 m, 95% CI: 70-216; P < 0.001] compared with usual care control in patients with non-metastatic cancer. In a meta-analysis of five randomized trials, anamorelin (a ghrelin agonist) significantly increased lean body mass [MD: +1.10 kg, 95% CI: 0.35-1.85; P = 0.004] but did not improve handgrip strength [MD: 0.52 kg, 95% CI: -0.09-1.13; P = 0.09] or overall survival compared with placebo [HR: 0.99, 95% CI: 0.85-1.14; P = 0.84] in patients with advanced or metastatic cancer. Early screening to identify individuals with occult muscle loss, combined with multimodal interventions that include lifestyle therapy with resistance exercise training and dietary supplementation combined with pharmacotherapy, may be necessary to provide a sufficient stimulus to prevent or slow the cascade of tissue wasting. Rapid, cost-efficient, and feasible methods to quantify muscle and adipose tissue distribution are needed if body composition assessment is to be integrated into large-scale clinical workflows. Fully automated analysis of body composition from clinically acquired imaging is one example. The study of body composition is one of the most provocative areas in oncology that offers tremendous promise to help patients with cancer live longer and healthier lives.

22 Editorial Central Obesity in Older Adults: What Should Be the Priority? 2018

Anderson, Cheryl A M / Mongraw-Chaffin, Morgana. ·1 University of California San Diego School of Medicine La Jolla CA. · 2 Wake Forest School of Medicine Winston-Salem NC. ·J Am Heart Assoc · Pubmed #30369332.

ABSTRACT: -- No abstract --

23 Editorial Comment on: Adipose tissue and the physiologic underpinnings of metabolic disease. 2018

Wisbach, Gordon G. ·Department of General Surgery, Naval Medical Center San Diego, San Diego, California. ·Surg Obes Relat Dis · Pubmed #30340866.

ABSTRACT: -- No abstract --

24 Editorial Comment on: postoperative outcomes based on patient participation in a presurgery education and weight management program. 2018

Felix, Edward L. ·Marian Hospital, Santa Maria, California. ·Surg Obes Relat Dis · Pubmed #30279079.

ABSTRACT: -- No abstract --

25 Editorial Target-Controlled Infusion: Not a One-Sized-Fits-All Answer to Drug Administration. 2018

Ingrande, Jerry / Lemmens, Hendrikus J. ·From the Department of Anesthesiology, University of California, San Diego School of Medicine, San Diego, California. · Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California. ·Anesth Analg · Pubmed #30216283.

ABSTRACT: -- No abstract --

Next